Chugai Pharmaceutical Co., Ltd. (TYO:4519)

Chugai Pharmaceutical Revenue

Chugai Pharmaceutical had revenue of 321.75B JPY in the quarter ending March 31, 2026, with 11.54% growth. This brings the company's revenue in the last twelve months to 1.29T, up 5.65% year-over-year. In the year 2025, Chugai Pharmaceutical had annual revenue of 1.26T with 7.46% growth.

• Revenue (ttm): 1.29T
• Revenue Growth: +5.65%
• P/S Ratio: 10.51
• Revenue / Employee: 252.98M
• Employees: 5,104
• Market Cap: 13.57T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.26T	87.33B	7.46%
Dec 31, 2024	1.17T	59.24B	5.33%
Dec 31, 2023	1.11T	-148.58B	-11.79%
Dec 31, 2022	1.26T	260.19B	26.02%
Dec 31, 2021	999.76B	212.81B	27.04%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error